<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05097820</url>
  </required_header>
  <id_info>
    <org_study_id>B6702020000588</org_study_id>
    <nct_id>NCT05097820</nct_id>
  </id_info>
  <brief_title>Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants</brief_title>
  <official_title>Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Groupe SEBBIN</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To analyze the short and long term postoperative clinical outcome and patient satisfaction of&#xD;
      silicone gel-filled testicular implants.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Testicular implants made from various materials have been in use since 1941. The lack of a&#xD;
      testicle has proven to be a psychologically traumatic experience for men of all ages.&#xD;
      Therefore, testicular implants are placed in the scrotum for various reasons on request of&#xD;
      the patient.The intended target population for the silicone gel-filled testicular implants of&#xD;
      Groupe SEBBIN is any patient (children or adults) with agenesis or testicular atrophy,&#xD;
      undescended testicle, testicular tumour, epididymitis / orchitis, or a trauma, for whom an&#xD;
      orchidectomy with placement of a testicular prosthesis is indicated. Testicular implants are&#xD;
      also indicated for sex reassignment surgeries.&#xD;
&#xD;
      The main complications after testicular implant placement recorded in the literature include&#xD;
      extrusion, scrotal contraction, pain, hematoma, and infection. The literature about&#xD;
      testicular implant is sparse, and no report on the use of SEBBIN silicone gel-filled&#xD;
      testicular implants have been identified in the scientific literature.&#xD;
&#xD;
      The Gel-filled Testicular Implant medical devices are manufactured by GROUPE SEBBIN under the&#xD;
      brand name 'Laboratoires SEBBIN'. The Gel-filled Testicular Implant medical devices are&#xD;
      presented sterile (Ethylene oxide sterilization) and are double wrapped for single use.&#xD;
&#xD;
      The medical grade raw materials used for the manufacturing of these prostheses are&#xD;
      bio-compatible and completely traceable. The substances belong to the polydimethylsiloxane&#xD;
      family.&#xD;
&#xD;
      This study is part of the clinical evaluation of SEBBIN silicone gel-filled testicular&#xD;
      implants, included in the technical file of the device. The aim of the study is to gather&#xD;
      data on the safety and effectiveness of the device. For this purpose, the overall short and&#xD;
      long term complication rate and complication grade. Secondly, the investigators evaluate&#xD;
      patient satisfaction and quality of life by use of questionnaires&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Short term complication rate</measure>
    <time_frame>Within 90 days postoperatively</time_frame>
    <description>Cathegorized according to Clavien-Dindo Classification</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Long term complication rate</measure>
    <time_frame>At 2 years of follow-up</time_frame>
    <description>Desciption of overall complications related to testicular prosthesis placement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in self-esteem scoring</measure>
    <time_frame>Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up</time_frame>
    <description>Assessed by the Rosenberg Self-Esteem Scale (strongly disagree - strongly agree)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body image of scrotum</measure>
    <time_frame>Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up</time_frame>
    <description>Assessed with non-validated likert scale quationnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with prosthesis</measure>
    <time_frame>Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up</time_frame>
    <description>Assessed with non-validated likert scale quationnaires</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Testicular Cancer</condition>
  <condition>Testicular Torsion</condition>
  <condition>Gender Dysphoria</condition>
  <condition>Undescended Testes</condition>
  <condition>Orchitis</condition>
  <condition>Testicular Agenesis</condition>
  <condition>Testicular Atrophy</condition>
  <condition>Prosthesis Durability</condition>
  <arm_group>
    <arm_group_label>Cisgender patients</arm_group_label>
    <description>All cisgender patients in which one or two testicular prostheses are to be implanted for various reasons.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transgender patients</arm_group_label>
    <description>All transgender patients in which one or two testicular prostheses are to be implanted for gender reassignment surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placement of testicular prosthesis</intervention_name>
    <description>The surgical implantation of one or two testicular prostheses on request of the patient</description>
    <arm_group_label>Cisgender patients</arm_group_label>
    <arm_group_label>Transgender patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any undividual with an underlying reason for testicular loss with a specific wish for&#xD;
        testicular implant placement.&#xD;
&#xD;
        Any patient with the underlying condidion of gender dysphoria with the specific wish for&#xD;
        testicular implant placement as a form of gender reassignment surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient is an adult or a child at the time of testicular implant placement.&#xD;
&#xD;
          -  The patient is a candidate to unilateral or bilateral testicular implant placement.&#xD;
&#xD;
          -  The patient has been informed of the study, has read the patient information letter&#xD;
             and provided oral and written consent.&#xD;
&#xD;
          -  If the patient is of French nationality, he/she must be affiliated to the French&#xD;
             Social Security.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient has silicone implants somewhere else than in the scrotal sac (except for a&#xD;
             penile prosthesis).&#xD;
&#xD;
          -  The patient was diagnosed with one of the following pathologies:&#xD;
&#xD;
        Systemic lupus erythematous, Sjogren syndrome, scleroderma, polymyositis, or any other&#xD;
        connective tissue disease.&#xD;
&#xD;
        Rheumatoid arthritis, crystalline arthritis, infectious arthritis, spondyloarthropathies,&#xD;
        or any other inflammatory arthritic disease.&#xD;
&#xD;
        Arthritis, fibromyalgia, chronic fatigue syndrome, or any other mechanic or degenerative&#xD;
        non-inflammatory rheumatic disease.&#xD;
&#xD;
        The patient has any other underlying condition that could delay healing.&#xD;
&#xD;
        - Custom-designed implants are used for surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Françoise Spinoit, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne-Françoise Spinoit, MD, PhD</last_name>
    <phone>003293322276</phone>
    <email>anne-francoise.spinoit@uzgent.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wietse Claeys, MD</last_name>
    <phone>003293322276</phone>
    <email>wietse.claeys@uzgent.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <state>East-Flanders</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Françoise Spinoit, MD, PhD</last_name>
      <phone>003293322276</phone>
      <email>anne-francoise.spinoit@uzgent.be</email>
    </contact>
    <contact_backup>
      <last_name>Wietse Claeys, MD, PhD</last_name>
      <phone>003293321702</phone>
      <email>wietse.claeys@uzgent.be</email>
    </contact_backup>
    <investigator>
      <last_name>Anne-Françoise Spinoit, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wietse Claeys, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Celine Sinatti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 21, 2021</study_first_submitted>
  <study_first_submitted_qc>October 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Ghent</investigator_affiliation>
    <investigator_full_name>Urologie</investigator_full_name>
    <investigator_title>Anne-Françoise Spinoit, MD, PhD, Staff member, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>testicular prosthesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testicular Neoplasms</mesh_term>
    <mesh_term>Cryptorchidism</mesh_term>
    <mesh_term>Orchitis</mesh_term>
    <mesh_term>Spermatic Cord Torsion</mesh_term>
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Prosthesis Failure</mesh_term>
    <mesh_term>Gender Dysphoria</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>After publication of findings, the individual patient data can be provided upon request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

